CN1745784A - 一种治疗上呼吸道感染的中药组合物及其制备方法 - Google Patents
一种治疗上呼吸道感染的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN1745784A CN1745784A CN 200410074599 CN200410074599A CN1745784A CN 1745784 A CN1745784 A CN 1745784A CN 200410074599 CN200410074599 CN 200410074599 CN 200410074599 A CN200410074599 A CN 200410074599A CN 1745784 A CN1745784 A CN 1745784A
- Authority
- CN
- China
- Prior art keywords
- add
- radix isatidis
- injection
- concentrate
- fructus gardeniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims description 24
- 206010057190 Respiratory tract infections Diseases 0.000 title claims description 17
- 206010046306 Upper respiratory tract infection Diseases 0.000 title claims description 17
- 239000003814 drug Substances 0.000 claims abstract description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 180
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 118
- 239000010231 banlangen Substances 0.000 claims description 73
- 239000012141 concentrate Substances 0.000 claims description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 58
- 238000002347 injection Methods 0.000 claims description 45
- 239000007924 injection Substances 0.000 claims description 45
- 238000002360 preparation method Methods 0.000 claims description 42
- 239000000706 filtrate Substances 0.000 claims description 33
- 230000006837 decompression Effects 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 26
- 238000001556 precipitation Methods 0.000 claims description 26
- 238000004321 preservation Methods 0.000 claims description 26
- 238000004064 recycling Methods 0.000 claims description 26
- 239000000843 powder Substances 0.000 claims description 22
- 238000011282 treatment Methods 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 15
- 239000002552 dosage form Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 239000008215 water for injection Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 3
- 239000000829 suppository Substances 0.000 claims description 3
- -1 tincture Substances 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 241000334160 Isatis Species 0.000 abstract description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 238000007493 shaping process Methods 0.000 abstract 1
- 235000008504 concentrate Nutrition 0.000 description 52
- 229940079593 drug Drugs 0.000 description 17
- 230000000844 anti-bacterial effect Effects 0.000 description 12
- 230000036760 body temperature Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 239000002158 endotoxin Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 206010036790 Productive cough Diseases 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 230000000630 rising effect Effects 0.000 description 5
- 208000024794 sputum Diseases 0.000 description 5
- 210000003802 sputum Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000000284 extract Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 3
- 229960000905 indomethacin Drugs 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007908 dry granulation Methods 0.000 description 2
- 210000001163 endosome Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241001147468 Chondrus ocellatus Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010062106 Respiratory tract infection viral Diseases 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 238000009400 out breeding Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
细菌 | 本发明制剂 | 板蓝根注射液 | 生理盐水 |
金黄色葡萄球菌白色葡萄球菌甲付伤寒杆菌乙付伤寒杆菌付寒杆杆大肠杆菌 | 3.6±1.12.8±0.73.0±1.14.6±1.63.3±0.84.0±1.1 | 2.7±1.13.5±1.01.9±1.12.5±1.32.7±1.04.1±1.4 | 000000 |
菌种 | 药物稀释浓度(g/ml) | ||||||||||
1∶1 | 1∶2 | 1∶4 | 1∶8 | 1∶16 | 1∶32 | 1∶64 | 1∶128 | 1∶256 | 1∶512 | NS | |
金葡菌白葡菌甲付伤寒杆菌乙付伤寒杆菌伤寒杆菌大肠杆菌 | ------ | ------ | -++--+ | +++--+ | ++++++ | ++++++ | ++++++ | ++++++ | ++++++ | ++++++ | ++++++ |
菌种 | 药物稀释浓度 | ||||||||||
1∶1 | 1∶2 | 1∶4 | 1∶8 | 1∶16 | 1∶32 | 1∶64 | 1∶128 | 1∶256 | 1∶512 | NS | |
金葡菌白葡菌甲付伤寒杆菌乙付伤寒杆菌伤寒杆菌大肠杆菌 | ------ | +--++- | ++-+++ | ++-+++ | ++++++ | ++++++ | ++++++ | ++++++ | ++++++ | ++++++ | ++++++ |
药物 | 动物数(只) | 死亡数(只) | 死亡率(%) | |||
24h | 48h | 72h | 7天共死 | |||
空白组生理盐水板蓝根小剂量组中剂量组大剂量组 | 202020202020 | 113833 | 154334 | 22221 | 117101398 | 5.085.050.0*65.045.0*40.0** |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410074599XA CN100352467C (zh) | 2004-09-09 | 2004-09-09 | 一种治疗上呼吸道感染的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410074599XA CN100352467C (zh) | 2004-09-09 | 2004-09-09 | 一种治疗上呼吸道感染的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1745784A true CN1745784A (zh) | 2006-03-15 |
CN100352467C CN100352467C (zh) | 2007-12-05 |
Family
ID=36165602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200410074599XA Expired - Lifetime CN100352467C (zh) | 2004-09-09 | 2004-09-09 | 一种治疗上呼吸道感染的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100352467C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007059649A1 (fr) * | 2005-11-25 | 2007-05-31 | Zhiquan Zhao | Preparation pharmaceutique chinoise traitant les infections des voies respiratoires et son procede d'elaboration |
CN102961467A (zh) * | 2012-12-06 | 2013-03-13 | 河北神威药业有限公司 | 一种清热解毒药物组合物及其原液的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169872A (zh) * | 1996-07-04 | 1998-01-14 | 刘华 | 中药退黄益肝制剂及其制备方法 |
-
2004
- 2004-09-09 CN CNB200410074599XA patent/CN100352467C/zh not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007059649A1 (fr) * | 2005-11-25 | 2007-05-31 | Zhiquan Zhao | Preparation pharmaceutique chinoise traitant les infections des voies respiratoires et son procede d'elaboration |
CN102961467A (zh) * | 2012-12-06 | 2013-03-13 | 河北神威药业有限公司 | 一种清热解毒药物组合物及其原液的制备方法 |
CN102961467B (zh) * | 2012-12-06 | 2014-08-06 | 河北神威药业有限公司 | 一种清热解毒药物组合物及其原液的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100352467C (zh) | 2007-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101041009A (zh) | 一种治疗咽喉炎的中药药物 | |
CN1772081A (zh) | 一种治疗腹泻病的中药组合物 | |
CN1883560A (zh) | 一种含金莲花的中药复方制剂及其制备方法 | |
CN105287790A (zh) | 一种鸡矢藤提取物及其应用 | |
CN1682842A (zh) | 一种消炎解毒的中药组合物及其制备方法和用途 | |
CN1943675A (zh) | 清热化痰、止咳平喘的藏药药物组合物及其制备方法 | |
CN104739960A (zh) | 肠胃抗菌药物组合物、含该组合物的肠胃抗菌药物及制备 | |
CN1739686A (zh) | 一种清热解毒中药注射制剂的制备方法及其制剂 | |
CN1745784A (zh) | 一种治疗上呼吸道感染的中药组合物及其制备方法 | |
CN103861007B (zh) | 一种治疗鸡腹泻的中草药复方制剂 | |
CN1733194A (zh) | 治疗呼吸系统疾病的组合中药材的提取物及提取方法 | |
WO2007059649A1 (fr) | Preparation pharmaceutique chinoise traitant les infections des voies respiratoires et son procede d'elaboration | |
CN1244332C (zh) | 九节茶提取物和它的应用 | |
CN100344319C (zh) | 治疗泌尿生殖系统疾病的中药组合物及其制备方法和用途 | |
CN1062148C (zh) | 复方甲冰滴耳液及其制备方法 | |
CN1799603A (zh) | 一种治疗风湿或类风湿的中药组合物及其制备方法 | |
CN1660347A (zh) | 银黄组合物、含有银黄组合物的口服和注射制剂及其制备方法和用途 | |
CN1634413A (zh) | 一种勒马回注射制剂及其制备方法 | |
CN1709489A (zh) | 治疗感冒风热症的中药组合物及其制备方法 | |
CN103656320A (zh) | 用于防治禽类风寒感冒、流感的口服复方中药制剂 | |
CN113499328B (zh) | 甘草查尔酮a在制备抗艰难梭菌感染药物中的应用 | |
CN1593564A (zh) | 一种治疗感冒的药物及其制备方法 | |
CN102836417B (zh) | 一种用于治疗仔猪白痢的药物组合物及其制备方法 | |
CN1257717C (zh) | 一种治疗顽固性仔猪下痢的药物及其制备方法 | |
CN1299707C (zh) | 一种银黄口服液及其生产工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1088232 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1088232 Country of ref document: HK |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Assignor: LUNAN PHARMACEUTICAL Group Corp. Contract record no.: 2010370000511 Denomination of invention: Chinese medicinal composition for treating upper respiratory tract infection Granted publication date: 20071205 License type: Exclusive License Open date: 20060315 Record date: 20100909 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211210 Address after: 276006 No. 209 Hongqi Road, Shandong, Linyi Patentee after: LUNAN HOPE PHARMACEUTICAL Co.,Ltd. Address before: 276005 No. 209 Hongqi Road, Shandong, Linyi Patentee before: LUNAN PHARMACEUTICAL Group Corp. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a traditional Chinese medicine composition for treating upper respiratory tract infection and a preparation method thereof Effective date of registration: 20211228 Granted publication date: 20071205 Pledgee: China Construction Bank Corporation Linyi Shizhong sub branch Pledgor: LUNAN HOPE PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980016801 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230331 Granted publication date: 20071205 Pledgee: China Construction Bank Corporation Linyi Shizhong sub branch Pledgor: LUNAN HOPE PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980016801 |